Liposomal Alpha-Galactosylceramide Ameliorates Graft-Versus-Host Disease with Remaining Intensified GVL Gained By Dose-Reduction of Posttransplant Cyclophosphamaide after Haploidentical HSCT

Makoto Nakamura; Ken‐ichi Matsuoka; Yusuke Meguri; Shuntaro Ikegawa; Hiroyuki Sugiura; Yasuhisa Sando; Miki Iwamoto; Takeru Asano; Yasuyuki Ishii; Yoshinobu Maeda

doi:10.1182/blood.v130.suppl_1.1897.1897

Liposomal Alpha-Galactosylceramide Ameliorates Graft-Versus-Host Disease with Remaining Intensified GVL Gained By Dose-Reduction of Posttransplant Cyclophosphamaide after Haploidentical HSCT

Identifier:nobleid.org/w1/20260515/84D0EEFC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/84D0EEFC.svg?ark=w1%2F20260515%2F84D0EEFC)](https://nobleid.org/work/w1/20260515/84D0EEFC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Liposomal Alpha-Galactosylceramide Ameliorates Graft-Versus-Host Disease with Remaining Intensified GVL Gained By Dose-Reduction of Posttransplant Cyclophosphamaide after Haploidentical HSCT

Identifier:nobleid.org/w1/20260515/84D0EEFC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/84D0EEFC.svg?ark=w1%2F20260515%2F84D0EEFC)](https://nobleid.org/work/w1/20260515/84D0EEFC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work